Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Christopher Savoie

Add links
From Wikipedia, the free encyclopedia
Dr.
Christopher Savoie
Savoie in 2019
Born (1971-01-19) January 19, 1971 (age 55)
Warwick, Rhode Island[1]
CitizenshipUnited States
Japan
OccupationsEntrepreneur, scientist, lawyer
Known forCo-inventor of natural language technology that contributed to the development of Siri[1][2][3]

Christopher Savoie (born January 19, 1971) is an American-Japanese entrepreneur, scientist, and lawyer. He has co-founded or led multiple ventures including Dejima Inc.,[4] Gene Networks International (GNI),[5] Kyulux,[6] and Zapata Computing,[7][8][9] with work spanning computational biology, natural-language systems, quantum algorithms, and industrial agentic AI. He is currently the co-founder and CEO of SiC Systems.[2] During his time at Dejima, his patented work on artificial intelligence with Babak Hodjat led to the technology used by Apple for their digital assistant Siri.[10][3][1]

Career

[edit]

Informatics and early ventures

[edit]

As a student in Japan, Savoie worked across computational biology and informatics, publishing on peptide motif inference in immunology and applying machine learning to epitope prediction.[11][12] He also contributed to work on peptide-binding groove dynamics.[13] Savoie established early web consultancies including Atmark and Webula[4] during the dot-com boom.

Dejima and natural-language systems

[edit]

In 1998, Savoie co-founded Dejima Inc. with Babak Hodjat and Makoto Amamiya to develop adaptive, agent-oriented architectures for natural-language interfaces.[14][15][16] The Adaptive Agent Oriented Software Architecture (AAOSA) approach that Savoie invented with Hodjat at Dejima was later used by Apple as the natural language interface in their digital assistant Siri.[1][17]

Gene Networks International (GNI)

[edit]

In 2001, Savoie co-founded Gene Networks International (GNI) based on his research on the application of Bayesian machine learning for systems pharmacology and drug design.[18][19] Savoie served as the CEO and led the company through an IPO on the Tokyo Stock Exchange on August 31, 2007. [20] As of December 13th, 2025, GNI Group Ltd. has a market cap of $880M.[21]

Nissan

[edit]

Savoie later served as Senior Manager of Enterprise Architecture at Nissan, where he worked on big-data analytics and AI for global processes.[19]

Kyulux

[edit]

In 2015, Savoie co-founded and served as CEO at Kyulux. The company applied machine learning methods to identify light-emitting molecules that require less energy to emit colored light for OLED displays. [17]

Zapata Computing

[edit]

In 2023, Zapata rebranded as Zapata AI with a focus on developing quantum-inspired generative AI applications for industrial-scale problems. In April 2024, Zapata AI became a public company listed on the NASDAQ stock exchange through a business combination with Andretti Acquisition Corp., a SPAC created by Michael Andretti.[22][7][23] In October 2024, the company announced it was ceasing operations.[24][25] In September 2025, the company announced a restart as Zapata Quantum, with a renewed focus on developing quantum computing software applications for enterprise use cases. [26][27]

SiC Systems

[edit]

In 2025, Savoie co-founded SiC Systems together with Seyed Soheil Mansouri, a professor of systems design at the Technical University of Denmark. The company is a Nashville-based venture applying agentic AI to complex manufacturing .[2]

[edit]

Savoie has served on the steering committee of the U.S. Quantum Economic Development Consortium (QED-C).[28] In 2023, he was named QED-C Quantum Law Chair.[29][30] He has also served as vice chair of the Big Data committee of the American Bar Association.[29]

Honors and awards

[edit]
  • 1999 MIT Technology Review Innovators Under 35[4]

Selected patents and publications

[edit]

Patents

  • US US6594684B1, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive agent-oriented software architecture", issued 2000-11-07[15]
  • US US6144989, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive interaction using an adaptive agent-oriented software architecture", issued 2003-07-15[31]
  • US US6772190B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Distributed parser of natural language input", issued 2004-08-03[32]
  • US US7430475B2, Imoto, Seiyo; Goto, Takao; Miyano, Satoru; Tashiro, Kosuke; De Hoon, Michiel; Savoie, Christopher J.; Kuhara, Saturo, "Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries", issued 2008-09-30[33]
  • US US7761499B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "System for automated reply to natural language input", issued 2010-07-20[34]

Publications

  • Sudo, Tohru; Kamikawaji, Nobuhiro; Kimura, Akinori; Date, Yukiji; Savoie, Christopher; Nakashima, Hisashi; Furuichi, Emiko; Kuhara, Satoru; Sasazuki, Takehiko (1995-11-15). "Differences in MHC class I self peptide repertoires among HLA-A2 subtypes". The Journal of Immunology. 155 (10): 4749–4756.[12]
  • Imoto, Seiya; Savoie, Christopher J.; Aburatani, Sachiyo; Kim, Sunyong; Tashiro, Kousuke; Kuhara, Satoru; Miyano, Satoru (2003). "Use of Gene Networks for Identifying and Validating Drug Targets". Journal of Bioinformatics and Computational Biology. 01 (03): 459–474.[35]
  • Savoie, Christopher; Aburatani, Sachiyo; Watanabe, Shouji; Eguchi, Yoshihiro; Muta, Shigeru; Imoto, Seiya; Miyano, Satoru; Kuhara, Satoru; Tashiro, Kosuke (2003-01-01). "Use of Gene Networks from Full Genome Microarray Libraries to Identify Functionally Relevant Drug-affected Genes and Gene Regulation Cascades". DNA Research. 10 (1): 19–25.[36]
  • Hurley, Daniel; Araki, Hiromitsu; Tamada, Yoshinori; Dunmore, Ben; Sanders, Deborah; Humphreys, Sally; Affara, Muna; Imoto, Seiya; Yasuda, Kaori; Tomiyasu, Yuki; Tashiro, Kosuke; Savoie, Christopher; Cho, Vicky; Smith, Stephen; Kuhara, Satoru; Miyano, Satoru; Charnock-Jones, D. Stephen; Crampin, Edmund J.; Print, Cristin G. (2012). "Gene network inference and visualization tools for biologists: application to new human transcriptome datasets". Nucleic Acids Research. 40 (6): 2377–2398.[37]
  • Kailasanathan, Rajiv; Clements, William R.; Boskabadi, Mohammad Reza; Gibford, Shawn M.; Papadakis, Emmanouil; Savoie, Christopher J.; Mansouri, Seyed Soheil (2025-08-29). "Quantum enhanced ensemble GANs for anomaly detection in continuous biomanufacturing". arXiv.org.[38]

References

[edit]
  1. 1 2 3 4 "Quantum Quest". The University of Rhode Island. 2019-03-25. Retrieved 2025-11-18.
  2. 1 2 3 Adams, Lucy (2025-10-14). "Siri inventor raises over €2M for quantum startup". Tech.eu. Retrieved 2025-12-01.
  3. 1 2 "Christopher Savoie '92". The University of Rhode Island. 2025-11-17. Retrieved 2025-11-18.
  4. 1 2 3 "Christopher J. Savoie". Innovators Under 35. Retrieved 2025-12-01.
  5. ↑ "About us". Gene Networks International. Retrieved 2025-12-01.
  6. ↑ Tremblay, Jean-François (2016-10-31). "Kyulux". Chemical & Engineering News. Retrieved 2025-12-01.
  7. 1 2 Bort, Julie (2024-01-19). "Today's GenAI models are cost and energy pigs. Quantum tech could fix that". Business Insider. Retrieved 2025-12-08.
  8. ↑ Keane, Jonathan (2022-06-07). "The race toward a new computing technology is heating up". CNBC. Retrieved 2025-12-01.
  9. ↑ Ray, Tiernan (2020-11-19). "Quantum computing now is a bit like SQL was in the late 80s: Wild and wooly and full of promise". ZDNET. Retrieved 2025-12-08.
  10. ↑ Swayne, Matt (2021-01-20). "TQD Exclusive: With A Front-Row Seat, Zapata's CEO Sees Reason for Excitement — But Not Hype — In Quantum". The Quantum Insider. Retrieved 2025-12-08.
  11. ↑ Savoie, C. J.; Kamikawaji, N.; Sasazuki, T.; Kuhara, S. (1998). "Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs". Biocomputing '99. WORLD SCIENTIFIC. pp. 182–189. doi:10.1142/9789814447300_0018. ISBN 978-981-02-3624-3. Retrieved 2025-12-13.
  12. 1 2 T, Sudo; N, Kamikawaji; A, Kimura; Y, Date; CJ, Savoie; H, Nakashima; E, Furuichi; S, Kuhara; T, Sasazuki (1995). "Differences in MHC class I self peptide repertoires among HLA-A2 subtypes". Journal of Immunology. 155 (10): 4749–4756. doi:10.4049/jimmunol.155.10.4749. ISSN 0022-1767. PMID 7594476.
  13. ↑ Toh, Hidehiro; Savoie, Christopher J.; Kamikawaji, Nobuhiro; Muta, Shigeru; Sasazuki, Takehiko; Kuhara, Satoru (2000-10-15). "Changes at the floor of the peptide-binding groove induce a strong preference for Proline at position 3 of the bound peptide: Molecular dynamics simulations of HLA-A*0217". Biopolymers. 54 (5): 318–327. doi:10.1002/1097-0282(20001015)54:5<318::AID-BIP30>3.0.CO;2-T. ISSN 0006-3525. PMID 10935972. Retrieved 2025-12-13.
  14. ↑ "2025 Company Profile & Team". Tracxn. 2023-01-19. Retrieved 2025-12-13.
  15. 1 2 Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto (2000-11-07). "Adaptive agent-oriented software architecture: US 6144989 A". Google Patents. Archived from the original on 2016-05-22. Retrieved 2017-12-14.
  16. ↑ Tremblay, Jean-François (2016-06-06). "In the Land of the Rising Sun, the climate improves for high-technology start-ups". Chemical & Engineering News. Retrieved 2025-12-13.
  17. 1 2 Tremblay, Jean-François (2025-10-01). "Kyulux". Chemical & Engineering News. Retrieved 2025-12-13.
  18. ↑ "Company Overview and Group Structure". 株式会社ジーエヌアイグループ (in Japanese). Retrieved 2025-12-13.
  19. 1 2 "Quantum Computing in 2022". MIT Sloan Club of New York. 2023-04-10. Retrieved 2025-12-13.
  20. ↑ "Japan's GNI completes IPO". The Pharmaletter. 2007-09-09. Retrieved 2025-12-13.
  21. ↑ "GNI Group Ltd. (2160.T) Stock Price, News, Quote & History". Yahoo Finance. Retrieved 2025-12-13.
  22. ↑ Pressman, Aaron (2024-04-02). "Quantum computing. Generative AI. Harvard startup Zapata goes public with all the buzzwords". BostonGlobe.com. Retrieved 2025-12-13.
  23. ↑ Baker, Liana (2023-09-06). "Michael Andretti's SPAC Finds Tech Target in Zapata AI". Bloomberg.com. Retrieved 2025-12-13.
  24. ↑ Swayne, Matt (2024-10-12). "Zapata Computing Holdings Inc. Ceases Operations". The Quantum Insider. Retrieved 2025-12-13.
  25. ↑ Pressman, Aaron (2024-10-15). "Boston quantum computing startup Zapata Computing goes bust". BostonGlobe.com. Retrieved 2025-12-13.
  26. ↑ Swayne, Matt (2025-09-03). "Viva Zapata -- Zapata Quantum Reemerges After Bankruptcy Filing With Restructuring and New Financing". The Quantum Insider. Retrieved 2025-12-13.
  27. ↑ "'That pivot ... really didn't work out:' Zapata Quantum CEO tells comeback story". Boston Business Journal. 2025-11-25. Retrieved 2025-12-13.
  28. ↑ Admin, QED-C (2020-09-11). "QED-C Steering Committee member Christopher Savoie breaks down the three steps toward becoming a quantum-capable organization". QED-C. Retrieved 2025-12-01.
  29. 1 2 AI, Zapata (2023-12-15). "Zapata AI CEO Christopher Savoie Appointed 2024 QED-C Quantum Law Chair". Business Wire. Retrieved 2025-12-01.
  30. ↑ Hertz, Jake (2025-05-20). "Generative AI for Dirty Jobs—The Next Industrial Revolution?". Engineering Podcast. Retrieved 2025-12-01.
  31. ↑ US US6144989, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive interaction using an adaptive agent-oriented software architecture", issued 2003-07-15
  32. ↑ US US6772190B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Distributed parser of natural language input", issued 2004-08-03
  33. ↑ US US7430475B2, Imoto, Seiyo; Goto, Takao; Miyano, Satoru; Tashiro, Kosuke; De Hoon, Michiel; Savoie, Christopher J.; Kuhara, Saturo, "Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries", issued 2008-09-30
  34. ↑ US US7761499B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "System for automated reply to natural language input", issued 2010-07-20
  35. ↑ Imoto, Seiya; Savoie, Christopher J.; Aburatani, Sachiyo; Kim, Sunyong; Tashiro, Kousuke; Kuhara, Satoru; Miyano, Satoru (2003). "Use of Gene Networks for Identifying and Validating Drug Targets". Journal of Bioinformatics and Computational Biology. 01 (3): 459–474. doi:10.1142/S0219720003000290. ISSN 0219-7200. PMID 15290765. Retrieved 2025-11-25.
  36. ↑ Savoie, C. J. (2003-01-01). "Use of Gene Networks from Full Genome Microarray Libraries to Identify Functionally Relevant Drug-affected Genes and Gene Regulation Cascades". DNA Research. 10 (1): 19–25. doi:10.1093/dnares/10.1.19. ISSN 1340-2838. PMID 12693551. Retrieved 2025-11-25.
  37. ↑ Hurley, Daniel; Araki, Hiromitsu; Tamada, Yoshinori; Dunmore, Ben; Sanders, Deborah; Humphreys, Sally; Affara, Muna; Imoto, Seiya; Yasuda, Kaori; Tomiyasu, Yuki; Tashiro, Kosuke; Savoie, Christopher; Cho, Vicky; Smith, Stephen; Kuhara, Satoru; Miyano, Satoru; Charnock-Jones, D. Stephen; Crampin, Edmund J.; Print, Cristin G. (2012). "Gene network inference and visualization tools for biologists: application to new human transcriptome datasets". Nucleic Acids Research. 40 (6): 2377–2398. doi:10.1093/nar/gkr902. ISSN 1362-4962. PMC 3315333. PMID 22121215.
  38. ↑ Kailasanathan, Rajiv; Clements, William R.; Boskabadi, Mohammad Reza; Gibford, Shawn M.; Papadakis, Emmanouil; Savoie, Christopher J.; Mansouri, Seyed Soheil (2025-08-29). "Quantum enhanced ensemble GANs for anomaly detection in continuous biomanufacturing". arXiv:2508.21438 [cs.LG].
Retrieved from "https://en.wikipedia.org/w/index.php?title=Christopher_Savoie&oldid=1363082171"